JANE TRICHE MILAZZO, District Judge.
Before the Court is Plaintiff Kelly Gahan's Motion for Reconsideration of Court's Order Granting in Part Sanofi's Motion for Rule 37 Sanctions (Doc. 4201). For the following reasons, the Motion is
For a discussion of the facts relevant to this dispute, see the Court's Order and Reasons dated August 22, 2018 (Doc. 3917).
A Motion for Reconsideration of an interlocutory order is governed by Federal Rule of Civil Procedure 54(b).
The goal of the multidistrict litigation process is to "promote the just and efficient conduct" of "civil actions involving one or more common questions of fact" that are pending in different districts.
Because multidistrict litigation is a "special breed of complex litigation where the whole is bigger than the sum of its parts," the district court "needs to have broad discretion to administer the proceeding as a whole, which necessarily includes keeping the parts in line."
Plaintiff Gahan has not identified any manifest error of law or fact or any newly discovered evidence. Gahan first asserts that the Court's order is based on a mistake of fact because the Court found that Gahan did not produce all of the photographs she sent to Dr. David Weinstein. At the same time, however, Gahan admits that her production was less than complete—she states that her production included "every photograph in Dr. Weinstein's production set except one."
Even if Gahan had produced every photograph she sent to Dr. Weinstein, the Court's sanctions order would remain sound. As the Court wrote in its Order and Reasons imposing sanctions, Rule 37(b)(2)(A) authorizes a district court to impose just sanctions on a party who refuses to obey a valid discovery order.
In its Order and Reasons, the Court made the specific factual finding that Gahan repeatedly omitted information from her Plaintiff Fact Sheet.
In Phenylpropanolamine (PPA) Products Liability Litigation, the Ninth Circuit upheld a district court's decision to dismiss cases in which plaintiffs delayed in completing their Plaintiff Facts Sheets.
The plaintiffs argued that their noncompliance was not the result of willfulness or bad faith, but the Ninth Circuit concluded that, because their conduct was not outside of their control, dismissal was an available sanction under Rule 37.
This Court is trying to manage this MDL as efficiently and justly as possible. In its original Order and Reasons, this Court concluded that, in light of Gahan's evasive conduct, which constitutes bad faith, sanctions were necessary to serve as a deterrent to other litigants in this MDL. The Court stands by its conclusion.
In her Motion for Reconsideration, Gahan further asserts that this Court made a mistake of fact in finding that Gahan provided no explanation for why she instructed the VA not to release her records. Gahan questions whether the Court reviewed her "supplemental brief" on this subject. The Court reviewed the brief and indeed found that Gahan provided no explanation—certainly not a satisfactory one.
The letter from the VA to Sanofi makes clear that Gahan had instructed the VA not to release her records; yet in her supplemental brief, Gahan denies that she gave any such instruction. The VA letter reads, "Dr. Gahan informed our office to not release her employment or medical records to Veritext and that she would provide her employment information directly to Veritext."
Plaintiff expects the Court to believe (1) that she did not instruct the VA to withhold her records and (2) that she was going to go the extra mile and obtain the full file herself. Tellingly, however, Gahan did not produce her employment records until Sanofi filed its supplemental brief and drew the Court's attention to Gahan's conduct. Frankly, Gahan's explanation is implausible. Her instruction to the VA fits into a larger picture of Gahan's evasive conduct. Accordingly, in the interests of a clear record, the Court specifically finds that Gahan instructed the VA to withhold her records from Sanofi. This supports the Court's general finding that Gahan is not complying with the discovery process in this case. Because this is an MDL and Gahan knows what is expected of her, sanctions were especially appropriate to stop Gahan— and to deter any other plaintiff—from interfering with discovery.
In another argument, Gahan asserts that Rule 37(a) does not allow the Court to award expenses to Sanofi. Rule 37(a) provides that, if the requested discovery is provided after the filing of a motion to compel, the court must require the party whose conduct necessitated the motion to pay the movant's reasonable expenses incurred in making the motion, including attorney's fees.
While this Court awarded Sanofi expenses under Rule 37(b), Gahan asserts that such an award normally requires a finding that the disobedient party failed to obey an order under Rule 37(a). While this may normally be so, this Court concludes that a violation of PTO 18 is sufficient to support Rule 37 sanctions in this MDL. The purpose of Rule 37 is to "provide[ ] generally for sanctions against parties or persons unjustifiably resisting discovery."
Lastly, Gahan argues that Rule 37(a)(1) requires a good faith conferral to resolve a discovery dispute without court action. As previously noted, an MDL court has broad discretion, and an MDL court may impose sanctions for the purpose of deterring other plaintiffs. The Court is not condoning the failure to confer that may have happened here, but the Court is making clear that the plaintiffs in this litigation are expected to comply with their discovery obligations.
For the foregoing reasons, Plaintiff Kelly Gahan's Motion for Reconsideration of Court's Order Granting in Part Sanofi's Motion for Rule 37 Sanctions (Doc. 4201) is
This language has remained in the Plaintiff Fact Sheet through rounds of revisions. See Doc. 688 (Pretrial Order No. 55) adopting revised Plaintiff Fact Sheet (Doc. 673-2).